Interference by butyl rubber stoppers in GLC analysis for theophylline. 1976

F Chrzanowski, and P J Niebergall, and R Mayock, and J Taubin, and E Sugita

During a study of the pharmacokinetics of theophylline using GLC analysis, unexpectedly high values occurred in a random manner. The cause of there abnormal values was investigated, and significant interference was observed when blood samples were drawn using evacuated glass tubes sealed with butyl rubber stoppers. In vitro tests using distilled water showed no apparent theophylline levels due to the additives in three commonly used tubes. However, when water was allowed to remain in contact with the butyl rubber stoppers for 1 min, an apparent theophylline content of as high as 5.5 mug/ml was observed. A contact time of 60 min resulted in apparent theophylline levels of as high as 52.3 mug/ml. It was concluded that a substance leached from the butyl rubber stoppers accounted for the spurious results.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D004349 Drug Packaging Containers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available. Drug Containers and Closures,Packaging, Drug,Drug Containers,Container, Drug,Containers, Drug,Drug Container,Drug Packagings,Packagings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012408 Rubber A high-molecular-weight polymeric elastomer derived from the milk juice (LATEX) of HEVEA brasiliensis and other trees and plants. It is a substance that can be stretched at room temperature to at least twice its original length and after releasing the stress, retract rapidly, and recover its original dimensions fully. Latex Rubber,Elastica,India Rubber,Natural Rubber,Plant Rubber,Vulcanite,Natural Rubbers,Plant Rubbers,Rubber, Natural,Rubber, Plant,Rubbers, Natural,Rubbers, Plant
D013806 Theophylline A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. 1,3-Dimethylxanthine,3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione,Accurbron,Aerobin,Aerolate,Afonilum Retard,Aquaphyllin,Armophylline,Bronchoparat,Bronkodyl,Constant-T,Elixophyllin,Euphylong,Glycine Theophyllinate,Lodrane,Monospan,Nuelin,Nuelin S.A.,Quibron T-SR,Slo-Phyllin,Somophyllin-T,Sustaire,Synophylate,Theo Von Ct,Theo-24,Theo-Dur,Theobid,Theocin,Theoconfin Continuous,Theodur,Theolair,Theolix,Theon,Theonite,Theopek,Theophylline Anhydrous,Theophylline Sodium Glycinate,Theospan,Theostat,Theovent,Uniphyl,Uniphyllin,Uniphylline,1,3 Dimethylxanthine,Anhydrous, Theophylline,Constant T,ConstantT,Ct, Theo Von,Glycinate, Theophylline Sodium,Quibron T SR,Quibron TSR,Slo Phyllin,SloPhyllin,Sodium Glycinate, Theophylline,Somophyllin T,SomophyllinT,Theo 24,Theo Dur,Theo24,Theophyllinate, Glycine,Von Ct, Theo

Related Publications

F Chrzanowski, and P J Niebergall, and R Mayock, and J Taubin, and E Sugita
January 1978, Farmatsiia,
F Chrzanowski, and P J Niebergall, and R Mayock, and J Taubin, and E Sugita
February 1966, Journal of bacteriology,
F Chrzanowski, and P J Niebergall, and R Mayock, and J Taubin, and E Sugita
January 1862, The Dental register,
F Chrzanowski, and P J Niebergall, and R Mayock, and J Taubin, and E Sugita
May 1977, Applied and environmental microbiology,
F Chrzanowski, and P J Niebergall, and R Mayock, and J Taubin, and E Sugita
January 1977, Farmatsiia,
F Chrzanowski, and P J Niebergall, and R Mayock, and J Taubin, and E Sugita
August 1935, American journal of public health and the nation's health,
F Chrzanowski, and P J Niebergall, and R Mayock, and J Taubin, and E Sugita
March 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
F Chrzanowski, and P J Niebergall, and R Mayock, and J Taubin, and E Sugita
January 1948, Bulletin. American Pharmaceutical Association. Committee on National Formulary,
F Chrzanowski, and P J Niebergall, and R Mayock, and J Taubin, and E Sugita
March 1955, Pharmaceutica acta Helvetiae,
F Chrzanowski, and P J Niebergall, and R Mayock, and J Taubin, and E Sugita
October 1995, Clinical chemistry,
Copied contents to your clipboard!